Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens
Open Access
- 1 September 2013
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 57 (9), 4237-4244
- https://doi.org/10.1128/aac.00277-13
Abstract
Trials to test new drugs currently in development against tuberculosis in humans are impractical. All animal models to prioritize new regimens are imperfect, but nonhuman primates (NHPs) infected with Mycobacterium tuberculosis develop active tuberculosis (TB) disease with a full spectrum of lesion types seen in humans. Serial 2-deoxy-2-[ 18 F]-fluoro- d -glucose (FDG) positron emission tomography (PET) with computed tomography (CT) imaging was performed on cynomolgus macaques during infection and chemotherapy with individual agents or the four-drug combination therapy most widely used globally. The size and metabolic activity of lung granulomas varied among animals and even within a single animal during development of disease. Individual granulomas within untreated animals had highly local and independent outcomes, some progressing in size and FDG uptake, while others waned, illustrating the highly dynamic nature of active TB. At necropsy, even untreated animals were found to have a proportion of sterile lesions consistent with the dynamics of this infection. A more marked reduction in overall metabolic activity in the lungs (decreased FDG uptake) was associated with effective treatment. A reduction in the size of individual lesions correlated with a lower bacterial burden at necropsy. Isoniazid treatment was associated with a transient increase in metabolic activity in individual lesions, whereas a net reduction occurred in most lesions from rifampin-treated animals. Quadruple-drug therapy resulted in the highest decrease in FDG uptake. The findings of PET-CT imaging may provide an important early correlate of the efficacy of novel combinations of new drugs that can be directly translated to human clinical trials.Keywords
This publication has 33 references indexed in Scilit:
- 18F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic responseThe International Journal of Tuberculosis and Lung Disease, 2012
- Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaquesProceedings of the National Academy of Sciences of the United States of America, 2012
- Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysisThe Lancet Infectious Diseases, 2010
- Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic countryBMC Infectious Diseases, 2010
- Review of Portable CT with Assessment of a Dedicated Head CT ScannerAmerican Journal of Neuroradiology, 2009
- Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine ModelAntimicrobial Agents and Chemotherapy, 2009
- The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse.2008
- Pulmonary Tuberculosis: Up-to-Date Imaging and ManagementAmerican Journal of Roentgenology, 2008
- Distribution of F-18 Fluorodeoxyglucose (F-18 FDG) in Abdominal Aortic Aneurysm: High Accumulation in Macrophages Seen on PET Imaging and ImmunohistologyClinical Nuclear Medicine, 2005
- Increased (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation.2002